CRISPR Therapeutics AG Profile Avatar - Palmy Investing

CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRIS…

Biotechnology
CH, Zug [HQ]

News

Theses · Events · Sentiments
Sentiments
25-01-14 40.00%

If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech …

25-01-09 81.20%

Some of the best possible returns for investors come by not going after megacaps, but instead pursuing stocks that have …

24-12-17 46.40%

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are …

End of CRSP's Analysis
CIK: 1674416 CUSIP: H17182108 ISIN: CH0334081137 LEI: - UEI: -
Secondary Listings
CRSP has no secondary listings inside our databases.